Assessing use-dependent inhibition of the cardiac Na( /-) current (I(Na)) in the PatchXpress automated patch clamp (Q39684518)

14 September 2017

title

Assessing use-dependent inhibition of the cardiac Na( /-) current (I(Na)) in the PatchXpress automated patch clamp (English)

1 reference

14 September 2017

Jacob R Penniman

1

1 reference

14 September 2017

David C Kim

series ordinal

2

1 reference

14 September 2017

Joseph J Salata

series ordinal

3

1 reference

14 September 2017

John P Imredy

series ordinal

4

1 reference

14 September 2017

publication date

22 June 2010

1 reference

Journal of Pharmacological and Toxicological Methods

14 September 2017

published in

1 reference

14 September 2017

volume

62

1 reference

14 September 2017

issue

2

1 reference

14 September 2017

page(s)

107-118

1 reference

Interactions of flecainide with guinea pig cardiac sodium channels. Importance of activation unblocking to the voltage dependence of recovery

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/J.VASCN.2010.06.007

Optimization of Ca(v)1.2 screening with an automated planar patch clamp platform

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VASCN.2010.06.007

Lidocaine block of cardiac sodium channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VASCN.2010.06.007

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VASCN.2010.06.007

Sodium channel inhibitor drug discovery using automated high throughput electrophysiology platforms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VASCN.2010.06.007

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VASCN.2010.06.007

Port-a-patch and patchliner: high fidelity electrophysiology for secondary screening and safety pharmacology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VASCN.2010.06.007

The Cardiac Arrhythmia Suppression Trial: first CAST ... then CAST-II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VASCN.2010.06.007

Automated electrophysiology in the preclinical evaluation of drugs for potential QT prolongation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VASCN.2010.06.007

Time-dependent changes in kinetics of Na current in single canine cardiac Purkinje cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VASCN.2010.06.007

Site-3 toxins and cardiac sodium channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VASCN.2010.06.007

Effects of III-IV linker mutations on human heart Na channel inactivation gating

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VASCN.2010.06.007

Automated planar electrode electrophysiology in drug discovery: examples of the use of QPatch in basic characterization and high content screening on Na(v), K(Ca)2.3, and K(v)11.1 channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VASCN.2010.06.007

Alfuzosin delays cardiac repolarization by a novel mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VASCN.2010.06.007

Effect of compound plate composition on measurement of hERG current IC(50) using PatchXpress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VASCN.2010.06.007

Automated electrophysiology in drug discovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VASCN.2010.06.007

Effect of sodium channel blockers on ST segment, QRS duration, and corrected QT interval in patients with Brugada syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VASCN.2010.06.007

Cardiac sodium channels and inherited electrophysiologic disorders: a pharmacogenetic overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VASCN.2010.06.007

Effects of halothane and isoflurane on fast and slow inactivation of human heart hH1a sodium channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VASCN.2010.06.007

Biophysics and structure of the patch and the gigaseal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VASCN.2010.06.007

Efficient characterization of use-dependent ion channel blockers by real-time monitoring of channel state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VASCN.2010.06.007

Application of PatchXpress planar patch clamp technology to the screening of new drug candidates for cardiac KCNQ1/KCNE1 (I Ks) activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VASCN.2010.06.007

Comparison of heterologously expressed human cardiac and skeletal muscle sodium channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VASCN.2010.06.007

Drug-induced Brugada syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VASCN.2010.06.007

Blockage of the sodium current in isolated single cells from rat ventricle with mexiletine and disopyramide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VASCN.2010.06.007

Improved throughput of PatchXpress hERG assay using intracellular potassium fluoride

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VASCN.2010.06.007

SCN5A channelopathies--an update on mutations and mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VASCN.2010.06.007

10.1016/J.VASCN.2010.06.007

7 January 2021

Identifiers

DOI

1 reference

release_dnu4ktq5ezegphpbeenmf4jtga

14 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dnu4ktq5ezegphpbeenmf4jtga

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference